Kiminori Fujimoto Selected Research

HABA

7/2022

Human T-cell lymphotropic virus type 1 (HTLV-1)-associated bronchioloalveolar disorder required differentiation from fibrotic chronic hypersensitivity pneumonitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kiminori Fujimoto Research Topics

Disease

14	Neoplasms (Cancer) 10/2022 - 06/2003
12	Bronchiectasis 11/2023 - 10/2002
11	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2023 - 10/2008
10	Idiopathic Pulmonary Fibrosis 12/2023 - 01/2010
6	Fibrosis (Cirrhosis) 11/2023 - 10/2002
5	Pneumonia (Pneumonitis) 01/2023 - 05/2008
5	Idiopathic Interstitial Pneumonias 10/2022 - 01/2010
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 09/2012
4	Inflammation (Inflammations) 06/2021 - 07/2010
4	Hepatocellular Carcinoma (Hepatoma) 11/2017 - 10/2007
3	Dermatomyositis (Dermatopolymyositis) 11/2023 - 01/2017
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2017 - 01/2011
3	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2017 - 06/2012
3	Cysts 01/2017 - 06/2012
3	Lymphadenopathy 03/2015 - 04/2006
3	Cryptogenic Organizing Pneumonia 10/2010 - 05/2008
2	Neoplasm Metastasis (Metastasis) 01/2024 - 02/2018
2	Granuloma 05/2023 - 11/2007
2	Thymic epithelial tumor 03/2023 - 04/2006
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023 - 01/2012
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 07/2022 - 12/2015
2	Melanoma (Melanoma, Malignant) 03/2022 - 01/2017
2	Hemorrhage 01/2020 - 10/2006
2	Vascular Diseases (Vascular Disease) 01/2020 - 01/2009
2	Cholangiocarcinoma 07/2017 - 05/2011
2	Birt-Hogg-Dube Syndrome 01/2017 - 06/2012
2	Lung Diseases (Lung Disease) 01/2017 - 11/2010
2	Liver Cirrhosis (Hepatic Cirrhosis) 05/2016 - 05/2011
2	Connective Tissue Diseases (Connective Tissue Disease) 12/2015 - 01/2013
2	Pneumothorax 03/2015 - 06/2012
2	Hepatitis 01/2012 - 07/2011
2	Organizing Pneumonia 11/2010 - 01/2007
2	Carcinoma (Carcinomatosis) 03/2008 - 06/2003
2	Pleural Effusion (Pleural Effusions) 10/2006 - 04/2006
1	Paraganglioma (Paragangliomas) 01/2024
1	Lymphoma (Lymphomas) 01/2024
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2024
1	Immunoglobulin G4-Related Disease 01/2024
1	Respiratory Insufficiency (Respiratory Failure) 11/2023
1	Rheumatoid Arthritis 11/2023
1	Pain (Aches) 10/2023
1	Disease Progression 06/2023
1	Polymyositis 03/2022
1	Adenocarcinoma 11/2021
1	Adenocarcinoma of Lung 11/2021
1	Carotid Artery Diseases 01/2020
1	Glucose Intolerance 01/2020
1	Human Influenza (Influenza) 01/2020
1	Insulin Resistance 01/2020
1	COVID-19 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2019
1	Coronary Aneurysm (Aneurysm, Coronary) 01/2019

Drug/Important Bio-Agent (IBA)

8	PeriostinIBA 12/2023 - 05/2011
7	Biomarkers (Surrogate Marker)IBA 12/2023 - 03/2008
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2024 - 01/2014
4	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2011
4	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 11/2023 - 01/2017
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2023 - 11/2010
3	CollagenIBA 01/2020 - 01/2009
3	lipoarabinomannan (LAM)IBA 01/2017 - 06/2012
2	nintedanibIBA 12/2023 - 06/2019
2	Contrast MediaIBA 03/2023 - 06/2003
2	AutoantibodiesIBA 10/2022 - 12/2015
2	AntibodiesIBA 10/2022 - 04/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2021 - 01/2020
2	AsbestosIBA 07/2020 - 07/2010
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2020
2	ferric oxide (iron oxide)IBA 04/2012 - 07/2011
2	Silicon Dioxide (Silica)FDA LinkGeneric 10/2008 - 02/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2008 - 06/2003
2	Capsules (Microcapsules)IBA 10/2006 - 04/2006
1	Immunoglobulin G (IgG)IBA 01/2024
1	Prednisolone (Predate)FDA LinkGeneric 11/2023
1	Calcineurin InhibitorsIBA 11/2023
1	Polidocanol (Laureth)FDA Link 10/2023
1	Antifibrotic AgentsIBA 06/2023
1	villin headpiece subdomain peptide (HP 36)IBA 05/2023
1	Antinuclear AntibodiesIBA 10/2022
1	HABAIBA 07/2022
1	transcriptional intermediary factor 1IBA 03/2022
1	Extracellular Matrix ProteinsIBA 11/2021
1	Clopidogrel (Plavix)FDA Link 06/2021
1	Prasugrel Hydrochloride FDA Link 06/2021
1	Periodic AcidIBA 07/2020
1	pigment epithelium-derived factorIBA 01/2020
1	ThrombomodulinIBA 01/2020
1	Pioglitazone (Actos)FDA Link 01/2020
1	Fluorine-18IBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 06/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2018

Therapy/Procedure

12	Traction 11/2023 - 10/2002
9	Therapeutics 01/2023 - 01/2005
2	Drug Tapering 04/2023 - 10/2022
2	Drug Therapy (Chemotherapy) 12/2017 - 09/2012
2	Radiotherapy 12/2017 - 05/2008
1	Sclerotherapy 10/2023
1	Precision Medicine 10/2021
1	Stents 06/2021